FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Galunisertib, 700874-72-2, Galunisertib Intermediate 106-40-1, stock 922.5g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| Galunisertib, 700874-72-2, Galunisertib Intermediate 78-94-4, stock 280.3g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| Galunisertib, 700874-72-2, Galunisertib Intermediate 41037-28-9, stock 512.8g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Galunisertib, 700874-72-2, Galunisertib Intermediate 13602-11-4, stock 898.5g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| Galunisertib, 700874-72-2, Galunisertib Intermediate 476472-28-3, stock 345.5g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| Galunisertib, 700874-72-2, Galunisertib Intermediate 20386-22-5, stock 117g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| Galunisertib, 700874-72-2, Galunisertib Intermediate 476473-54-8, stock 300.5g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| Galunisertib, 700874-72-2, Galunisertib Intermediate 476474-52-9, stock 650.9g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| Galunisertib, 700874-72-2, Galunisertib Intermediate 476475-44-2, stock 892.6g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
